|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-4.49% | -0.54% |
| 22-03-28 | Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022 | CI |
| 20-01-16 | Novelion Therapeutics Inc. Announces Management Changes | CI |
| Market Cap | 13.85M 12.18M 11.31M 10.41M 19.51M 1.34B 19.86M 135M 52.77M 654M 51.98M 50.86M 2.27B | P/E 2017 |
-0.46x | P/E 2018 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 317M 279M 259M 238M 447M 30.72B 455M 3.1B 1.21B 14.98B 1.19B 1.17B 51.98B | EV / Sales 2017 |
1,887,512x | EV / Sales 2018 | 2,447,567x |
| Free-Float |
-
| Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/9/20 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,317 | 0.0067% | |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Other | Company | 0 | 0% | |
| 4/9/20 | Edgepoint Investment Group, Inc.
| Buy | Company | 1,833 | 0.0093% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 138.44 121.76 113.11 104.03 195.09 13.41K 198.59 1.35K 527.57 6.54K 519.72 508.48 22.69K | 130.43 114.71 106.57 98.01 183.81 12.63K 187.1 1.27K 497.06 6.16K 489.67 479.08 21.37K |
| Net income | -127M -111M -104M -95.22M -179M -12.27B -182M -1.24B -483M -5.99B -476M -465M -20.76B | -108M -95.27M -88.51M -81.4M -153M -10.49B -155M -1.06B -413M -5.12B -407M -398M -17.75B |
| Net Debt | 203M 179M 166M 153M 286M 19.67B 291M 1.98B 774M 9.59B 763M 746M 33.28B | 303M 267M 248M 228M 427M 29.38B 435M 2.96B 1.16B 14.33B 1.14B 1.11B 49.71B |
Employees
-
Sector
-
- Stock Market
- Stocks
- NVLNF Stock
Select your edition
All financial news and data tailored to specific country editions
